1
Total investments
1
Early stage
0
Mid stage
0
Late stage
5y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Seed Investor
Jun 2021
Founded in 2021, Endear Health is a white-labeled onboarding & engagement platform, purposefully built for Medicare Advantage plans, Direct Contracting Entities, and all organizations taking on risk.
Endear Health believes that seniors who are accustomed to receiving extra assistance and care across nearly all facets of their daily lives should receive that same high level of support when it comes to how they access healthcare.
Find out more about Endear Health: visit endearhealth.com
Experience · 2 entries
All (2)
Investments (1)
2021
Seed Investor
Jun 2021
Founded in 2021, Endear Health is a white-labeled onboarding & engagement platform, purposefully built for Medicare Advantage plans, Direct Contracting Entities, and all organizations taking on risk.
Endear Health believes that seniors who are accustomed to receiving extra assistance and care across nearly all facets of their daily lives should receive that same high level of support when it comes to how they access healthcare.
Find out more about Endear Health: visit endearhealth.com
2019
Associate Consultant
Jul 2019
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.